deferoxamine has been researched along with minocycline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Connor, JR; Lee, SY; Mitchell, RM; Randazzo, WT; Simmons, Z | 1 |
| Chen, L; Chen-Roetling, J; Regan, RF | 1 |
| Connor, JR; Lee, SY; Mitchell, RM; Simmons, Z | 1 |
| Beeson, CC; Hu, J; Jaeschke, H; Kholmukhamedov, A; Lemasters, JJ; Lindsey, CC | 1 |
| Adelusi, OB; Jaeschke, H; Lemasters, JJ; Ramachandran, A | 1 |
1 review(s) available for deferoxamine and minocycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for deferoxamine and minocycline
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line, Tumor; Chemokine CCL2; Chromans; Deferoxamine; Ferric Compounds; Gene Expression; Heat-Shock Proteins; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron; Iron Chelating Agents; Membrane Proteins; Mice; Microglia; Minocycline; Neurons; NF-kappa B; Polymorphism, Single Nucleotide; Quaternary Ammonium Compounds; RNA, Messenger | 2009 |
Minocycline attenuates iron neurotoxicity in cortical cell cultures.
Topics: Animals; Cerebral Cortex; Cerebral Hemorrhage; Cytoprotection; Deferoxamine; Iron; Iron Chelating Agents; Mice; Mice, Inbred Strains; Minocycline; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes | 2009 |
HFE polymorphisms affect cellular glutamate regulation.
Topics: Analysis of Variance; Calcium; Cell Line, Tumor; Deferoxamine; Enzyme Inhibitors; Ferric Compounds; Gene Expression Regulation, Neoplastic; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Glutaminase; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Intracellular Fluid; Iron; Membrane Proteins; Minocycline; Neuroblastoma; Polymorphism, Genetic; Quaternary Ammonium Compounds; Siderophores; Sodium; Tacrine; Transfection; Tritium; Vesicular Glutamate Transport Protein 1 | 2011 |
Translocation of iron from lysosomes to mitochondria during acetaminophen-induced hepatocellular injury: Protection by starch-desferal and minocycline.
Topics: Acetaminophen; Animals; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Deferoxamine; Drug Evaluation, Preclinical; Hepatocytes; Iron; Iron Chelating Agents; Lysosomes; Male; Mice, Inbred C57BL; Minocycline; Mitochondria; Oxidative Stress; Reactive Oxygen Species; Ruthenium Compounds; Starch | 2016 |
The role of Iron in lipid peroxidation and protein nitration during acetaminophen-induced liver injury in mice.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Deferoxamine; Hepatocytes; Iron; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred C57BL; Minocycline; Mitochondria, Liver; Oxidative Stress; Peroxynitrous Acid | 2022 |